Molecular networks involved in the immune control of BK polyomavirus
Language English Country Egypt Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23251224
PubMed Central
PMC3521483
DOI
10.1155/2012/972102
Knihovny.cz E-resources
- MeSH
- Biopsy methods MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Kidney Diseases genetics immunology virology MeSH
- Polyomavirus Infections genetics immunology MeSH
- Transcriptome MeSH
- Kidney Transplantation adverse effects immunology MeSH
- BK Virus genetics immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BK polyomavirus infection is the important cause of virus-related nephropathy following kidney transplantation. BK virus reactivates in 30%-80% of kidney transplant recipients resulting in BK virus-related nephropathy in 1%-10% of cases. Currently, the molecular processes associated with asymptomatic infections in transplant patients infected with BK virus remain unclear. In this study we evaluate intrarenal molecular processes during different stages of BKV infection. The gene expression profiles of 90 target genes known to be associated with immune response were evaluated in kidney graft biopsy material using TaqMan low density array. Three patient groups were examined: control patients with no evidence of BK virus reactivation (n = 11), infected asymptomatic patients (n = 9), and patients with BK virus nephropathy (n = 10). Analysis of biopsies from asymptomatic viruria patients resulted in the identification of 5 differentially expressed genes (CD3E, CD68, CCR2, ICAM-1, and SKI) (P < 0.05), and functional analysis showed a significantly heightened presence of costimulatory signals (e.g., CD40/CD40L; P < 0.05). Gene ontology analysis revealed several biological networks associated with BKV immune control in comparison to the control group. This study demonstrated that asymptomatic BK viruria is associated with a different intrarenal regulation of several genes implicating in antiviral immune response.
See more in PubMed
Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. Journal of the American Society of Nephrology. 1999;10(5):1080–1089. PubMed
Costa C, Bergallo M, Astegiano S, et al. Monitoring of BK virus replication in the first year following renal transplantation. Nephrology Dialysis Transplantation. 2008;23(10):3333–3336. PubMed
Hariharan S. BK virus nephritis after renal transplantation. Kidney International. 2006;69(4):655–662. PubMed
Alméras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation. 2008;85(8):1099–1104. PubMed
Hirsch HH. BK virus: opportunity makes a pathogen. Clinical Infectious Diseases. 2005;41(3):354–360. PubMed
Costa C, Bergallo M, Sidoti F, et al. Polyomaviruses BK- and JC-DNA quantitation in kidney allograft biopsies. Journal of Clinical Virology. 2009;44(1):20–23. PubMed
Schachtner T, Muller K, Stein M, et al. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. American Journal of Transplantation. 2011;11(11):2443–2452. PubMed
Girmanova E, Brabcova I, Bandur S, Hribova P, Skibova J, Viklicky O. A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients. Journal of Medical Virology. 2011;83(8):1395–1400. PubMed
Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277–1286. PubMed
Platzer C, Ode-Hakim S, Reinke P, Docke WD, Ewert R, Volk HD. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation. 1994;58(2):264–268. PubMed
Notebaart RA, Teusink B, Siezen RJ, Papp B. Co-regulation of metabolic genes is better explained by flux coupling than by network distance. PLoS Computational Biology. 2008;4(1, article e26) PubMed PMC
Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. Nature Genetics. 2000;25(1):25–29. PubMed PMC
Holec M, Zelezny F, Klema J, Tolar J. Integrating multiple-platform expression data through gene set features. Proceedings of the 5th International Conference on Bioinformatics Research and Applications (ISBRA '09); 2009.
Holec M, Zelezny F, Klema J, Tolar J. Cross-genome knowledge-based expression data fusion. Proceedings of the International Conference on Bioinformatics, Computational Biology, Genomics and Chemoinformatics (BCBGC '09); 2009.
Rhee J, Al-Mana N, Freeman R. Immunosuppression in high-risk transplantation. Current Opinion in Organ Transplantation. 2009;14(6):636–642. PubMed
Babel N, Volk HD, Reinke P. BK polyomavirus infection and nephropathy: the virus-immune system interplay. Nature Reviews Nephrology. 2011;7(7):399–406. PubMed
Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Current Opinion in Organ Transplantation. 2008;13(6):569–574. PubMed
Christensen JE, Thomsen AR. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 2009;117(5-6):338–355. PubMed
Mueller K, Schachtner T, Sattler A, et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation. 2011;91(1):100–107. PubMed
van Kooten G, Banchereau J. CD40-CD40 ligand. Journal of Leukocyte Biology. 2000;67(1):2–17. PubMed
Pandiyan P, Hegel JKE, Krueger M, Quandt D, Brunner-Weinzierl MC. High IFN-γ production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4) Journal of Immunology. 2007;178(4):2132–2140. PubMed
Munroe ME. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Seminars in Immunology. 2009;21(5):283–288. PubMed
Zhou W, Sharma M, Martinez J, et al. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunology. 2007;20(3):379–388. PubMed
Abend JR, Low JA, Imperiale MJ. Global effects of BKV infection on gene expression in human primary kidney epithelial cells. Virology. 2010;397(1):73–79. PubMed PMC
Mannon RB, Hoffmann SC, Kampen RL, et al. Molecular evaluation of BK polyomavirus nephropathy. American Journal of Transplantation. 2005;5(12):2883–2893. PubMed
Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. American Journal of Transplantation. 2005;5(3):573–581. PubMed
Mannon RB, Kirk AD. Beyond histology: novel tools to diagnose allograft dysfunction. Clinical journal of the American Society of Nephrology. 2006;1(3):358–366. PubMed
Schachtner T, Müller K, Stein M, et al. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. American Journal of Transplantation. 2011;11(11):2443–2452. PubMed
Seemayer CA, Seemayer NH, Dürmüller U, et al. BK virus large T and VP-1 expression in infected human renal allografts. Nephrology Dialysis Transplantation. 2008;23(12):3752–3761. PubMed PMC